Canopy Growth (CGC) Cash from Operations (2019 - 2026)
Canopy Growth (CGC) posted Cash from Operations of 32664714.37 for Q4 2025, down 337.84% sequentially from 7460342.11 in Q2 2025, and down 69.22% YoY from 106108586.1 in Q4 2024.
Canopy Growth (CGC) Cash from Operations (2019 - 2026) Analysis & Trends
Canopy Growth has reported Cash from Operations for 7 years, with the latest figure at 32664714.37 in Q4 2025.
- Quarterly Cash from Operations fell 69.22% year-over-year to 32664714.37 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 98905036.64 (up 12.48% YoY) and the FY2026 annual result came in at 46527698.38, up 59.72% from the prior year.
- Cash from Operations slipped to 32664714.37 in Q4 2025 per CGC's latest filing, from 7460342.11 in the prior quarter.
- Over five years, Cash from Operations peaked at 17298539.2 in Q1 2023 and troughed at 144448292.26 in Q4 2022.
- A 5-year average of 60043670.14 and a median of 50875761.15 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations jumped 180.68% in 2023, then slumped 194.63% in 2024.
- Over 5 years, Cash from Operations stood at 132788593.34 in 2021, then dropped by 8.78% to 144448292.26 in 2022, then jumped by 83.44% to 23923087.58 in 2023, then grew by 19.31% to 19303587.92 in 2024, then plunged by 69.22% to 32664714.37 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods registered 32664714.37, 7460342.11, and 19303587.92 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Canopy Growth | 437.04 Mn | 190.03 Mn | 16.08 Mn | -18.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -18.08 Mn |
| Jun 30, 2026 | -18.08 Mn |
| Dec 31, 2025 | -32.66 Mn |
| Dec 31, 2025 | -32.66 Mn |
| Jun 30, 2025 | -7.46 Mn |
| Jun 30, 2025 | -7.46 Mn |
| Dec 31, 2024 | -19.30 Mn |
| Dec 31, 2024 | -19.30 Mn |
| Sep 30, 2024 | -39.48 Mn |
| Sep 30, 2024 | -39.48 Mn |
| Jun 30, 2024 | -37.86 Mn |
| Jun 30, 2024 | -37.86 Mn |
| Mar 31, 2024 | -16.37 Mn |
| Mar 31, 2024 | -16.37 Mn |
| Dec 31, 2023 | -23.92 Mn |
| Dec 31, 2023 | -23.92 Mn |
| Sep 30, 2023 | -90.33 Mn |
| Sep 30, 2023 | -90.33 Mn |
| Jun 30, 2023 | -79.07 Mn |
| Jun 30, 2023 | -79.07 Mn |